Cannabis for Schizophrenia

Studies and Information on Cannabis for Schizophrenia

Schizophrenia remains one of the most common and serious yet least understood mental illnesses in the world today. Swiss psychiatrist Eugene Bleuler first used the word “schizophrenia” in 1911, which he derived from the Greek words schizo (to split) and phren (brain or mind).

However, unlike common usage suggests, it does not necessarily refer to a split personality(-ies) but rather a split or disconnect between thinking and feeling. Symptoms often include hallucinations involving the senses, making it difficult for patients to communicate or connect to others and the world.

Ratings for Cannabis and Schizophrenia

Rated 3.3 / 5 (How Ratings Work)

Likely probability of the efficacy of cannabis for treatment of schizophrenia.
Based on 12 Studies from 2004 - 2017

Studies on Cannabis and Schizophrenia

Study Name, Description & Year


Cannabidiol (CBD) As An Adjunctive Therapy In Schizophrenia: A Multicenter Randomized Controlled Trial
A double-blind parallel-group trial conducted on 88 patients with schizophrenia. — 2017


Cannabidiol Enhances Anandamide Signaling And Alleviates Psychotic Symptoms Of Schizophrenia
A double-blind, randomized clinical trial of cannabidiol vs amisulpride conducted on 47 patients suffering from schizophrenia. — 2012


S39-02 Antipsychotic Effects Of Cannabidiol
42 patients fulfilling DSM-IV criteria of acute paranoid schizophrenia — 2009